CM Hospitalar SA
CM Hospitalar S/A engages in the distribution of hospital materials, medicines, and nutrition products in Brazil. The company offers ophthalmic agent, adrenergic and thrombopoietin agonist, aminoglycosides, painkiller, anesthetics, receptor antagonist, anti-hemorrhoidal, antihypertensives, systemic antihistamine, and orthopedic therapy materials; and anti-inflammatories, anti-TNF, antacid, antian… Read more
CM Hospitalar SA (VVEO3) - Net Assets
Latest net assets as of September 2025: R$2.01 Billion BRL
Based on the latest financial reports, CM Hospitalar SA (VVEO3) has net assets worth R$2.01 Billion BRL as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (R$9.06 Billion) and total liabilities (R$7.05 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | R$2.01 Billion |
| % of Total Assets | 22.23% |
| Annual Growth Rate | 27.56% |
| 5-Year Change | 60.41% |
| 10-Year Change | N/A |
| Growth Volatility | 77.65 |
CM Hospitalar SA - Net Assets Trend (2017–2024)
This chart illustrates how CM Hospitalar SA's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for CM Hospitalar SA (2017–2024)
The table below shows the annual net assets of CM Hospitalar SA from 2017 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | R$1.93 Billion | -41.43% |
| 2023-12-31 | R$3.29 Billion | +44.24% |
| 2022-12-31 | R$2.28 Billion | +6.02% |
| 2021-12-31 | R$2.15 Billion | +79.10% |
| 2020-12-31 | R$1.20 Billion | +214.53% |
| 2019-12-31 | R$381.85 Million | +7.69% |
| 2018-12-31 | R$354.60 Million | +1.17% |
| 2017-12-31 | R$350.50 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to CM Hospitalar SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 452.2% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | R$2.55 Billion | 132.33% |
| Total Equity | R$1.93 Billion | 100.00% |
CM Hospitalar SA Competitors by Market Cap
The table below lists competitors of CM Hospitalar SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
BRAIN Biotech AG
XETRA:BNN
|
$40.42 Million |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
$40.42 Million |
|
Alexanderwerk Aktiengesellschaft
F:ALXA
|
$40.43 Million |
|
Peoples Financial Corp
OTCQX:PFBX
|
$40.43 Million |
|
Guler Yatirim Holding AS
IS:GLRYH
|
$40.41 Million |
|
NRX Pharmaceuticals Inc
NASDAQ:NRXP
|
$40.41 Million |
|
Many Peaks Minerals Ltd
AU:MPK
|
$40.40 Million |
|
EUWAX Aktiengesellschaft
F:EUX
|
$40.39 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CM Hospitalar SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 3,289,360,000 to 1,926,522,000, a change of -1,362,838,000 (-41.4%).
- Net loss of 1,415,491,000 reduced equity.
- Dividend payments of 43,482,000 reduced retained earnings.
- Share repurchases of 18,721,000 reduced equity.
- Other factors increased equity by 114,856,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | R$-1.42 Billion | -73.47% |
| Dividends Paid | R$43.48 Million | -2.26% |
| Share Repurchases | R$18.72 Million | -0.97% |
| Other Changes | R$114.86 Million | +5.96% |
| Total Change | R$- | -41.43% |
Book Value vs Market Value Analysis
This analysis compares CM Hospitalar SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.22x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.11x to 0.22x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | R$1.22 | R$1.36 | x |
| 2018-12-31 | R$1.24 | R$1.36 | x |
| 2019-12-31 | R$1.33 | R$1.36 | x |
| 2020-12-31 | R$4.20 | R$1.36 | x |
| 2021-12-31 | R$8.57 | R$1.36 | x |
| 2022-12-31 | R$8.05 | R$1.36 | x |
| 2023-12-31 | R$10.28 | R$1.36 | x |
| 2024-12-31 | R$6.10 | R$1.36 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CM Hospitalar SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -73.47%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -12.22%
- • Asset Turnover: 1.21x
- • Equity Multiplier: 4.95x
- Recent ROE (-73.47%) is below the historical average (1.64%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 16.77% | 3.47% | 1.20x | 4.02x | R$23.73 Million |
| 2018 | 9.61% | 1.29% | 1.23x | 6.08x | R$-1.37 Million |
| 2019 | 9.36% | 1.19% | 1.44x | 5.48x | R$-2.44 Million |
| 2020 | 10.14% | 2.76% | 0.96x | 3.83x | R$1.66 Million |
| 2021 | 18.37% | 6.35% | 0.90x | 3.21x | R$180.05 Million |
| 2022 | 11.39% | 2.97% | 0.91x | 4.19x | R$31.69 Million |
| 2023 | 10.94% | 3.25% | 1.09x | 3.10x | R$30.98 Million |
| 2024 | -73.47% | -12.22% | 1.21x | 4.95x | R$-1.61 Billion |
Industry Comparison
This section compares CM Hospitalar SA's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $518,887,000
- Average return on equity (ROE) among peers: 6.63%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CM Hospitalar SA (VVEO3) | R$2.01 Billion | 16.77% | 3.50x | $40.41 Million |
| Profarma Distribuidora de Produtos Farmacêuticos S.A (PFRM3) | $518.89 Million | 6.63% | 1.06x | $40.42 Million |